May 22, 2009 - Used for development of assays for monitoring protein production and biomarker quantitation, dotLab® System is available with software that provides technical controls to support 21 CFR Part 11 compliance. Features include secure database, audit trails, electronic signature controls, and user name/password controls. Software also aids implementation of controlled assays and provides users with flexible single platform for assay development, validation, and transfer between labs.

See related product stories
	Fluorescence-Based Assay measures global DNA methylation.
	Biochip covers entire mouse genome for DNA/RNA detection.
	Label-Free Instruments are designed for high throughput.
	Caco-2 Assay arrives ready to use at room temperature.
	Oxidation Assay is optimized for quickness and sensitivity.

See more product news in:
	Test and Measuring Instruments

Tools for you
del.icio.us	DIGG
Facebook	Reddit
StumbleUpon	Twitter
Print This Page	E-Mail Story
Watch_Company	Save Story
Contact company	View Company Profile
Company web site
More news from this company

More Tools and information

Search for suppliers of

Assaying Supplies

Join the forum discussion at:

Tools of the Trade

Newsletters

Your Gateway to a Fast Changing World Product News Alerts
	Receive similar stories and other customized news to keep you in the know on the products shaping industry.
	Subscribe Free Today Subscribe View Sample

Industry Market Trends Has Got It
Latest developments Trends Best practices Opinions & Commentary
Get Ahead. Get IMT. Subscribe Free Today Subscribe View Sample

See more related product stories:
	Transfection System speeds cell-based assay development.
	Laboratory Instrument characterizes interfering substances.
	Quantification System provides RNA detection.
	No-Wash Calcium Flux Assay is designed for GPCR screening.
	Content Screening Readers can run live-cell kinetic assays.
	Assays help detect and monitor thyroid conditions.
	Replicating Tool facilitates assay miniaturization.

Axela Introduces Software to Support 21 CFR Part 11 Compliance for Regulated Environments

TORONTO, May 7 -- Axela Inc., is pleased to announce the release of a software package for the dotLab(R) System that provides technical controls to support compliance with 21 CFR Part 11 regulations. This new package will be of particular interest to those working in pharmaceutical, biotech or other regulated environments. Features include a secure database, audit trails, electronic signature controls and user name/password controls.

"The dotLab System has proven its value in the rapid development of assays for monitoring protein production and biomarker quantitation. Axela is committed to further expanding the applications for our technology platform and increasing functionality" said Rocky Ganske, President and CEO, Axela Inc. "The new 21 CFR Part 11 Compliance Support Software simplifies implementation of controlled assays and provides dotLab System users with a flexible single platform for development, validation and transfer of assays between labs."

This new software is an integral component in Axela's suite of tools that significantly accelerate biomarker and assay development. Based on unique optics technology, the dotLab system allows reagent qualification, assay development and routine quantitative analysis to be combined into a single platform. panelPlus(TM) Sensors provide the industry's first real time, user configurable multiplex and have been designed to facilitate validation of both clinical utility and analytical performance. Panel constituents selected from a menu of established biomarkers can be freely combined with proprietary targets to allow direct comparison in a single sample. To further facilitate independent validation the same reagents are available in an orthogonal plate based EIA format. panelPlus Sensors are currently in use by Axela collaborators and will be commercially available this summer.

About Axela Inc.

Axela's products deliver rapid understanding of biological interactions, and use real time information to significantly improve the amount and quality of information derived from traditional immunoassay. This approach shortens time to result, greatly simplifies multiplexing and provides access to unique categories of markers that form a pipeline of future diagnostic offerings. Axela has operations in Toronto and California. Its major investor is VenGrowth Private Equity Partners Inc.

CONTACT: To order or for more information, please visit http://www.axela.com/ or contact: Mr. Paul Smith, VP Sales and Business Planning, Axela Inc., Phone: (416) 260-9050 x2291, E-mail: p.smith@axela.com

Contacts:

Sales:
Paul Smith VP Sales and Business Planning
USA
Phone: 416-260-9050 ext 2291

E-mail this person

Company Information:
Name: Axela Inc.
Address: 480 University Avenue
City: Toronto
ZIP: M5G 1V2
Country: Canada
Phone: 416-260-9050 ext 2251
FAX: 416-260-9255
http://www.axela.com

Brought to you by Thomasnet.com Browse ThomasNet Directory

News provided by ThomasNet News^® (TNN). TNN is a comprehensive source of new and timely product information in the industrial marketplace. TNN supplies new product information to the web sites, e-marketplaces and print publications that serve the industrial marketplace. For press release submissions please go to http://news.thomasnet.com/submitpr.html. BY ACCESSING, BROWSING AND/OR USING THIS WEB SITE AND/OR ANY WEB SITES PROVIDED BY ProductNews.com, YOU AGREE TO BE BOUND BY THE TERMS OF USE AGREEMENT.

Assay System supports 21 CFR Part 11 compliance.

Axela Introduces Software to Support 21 CFR Part 11 Compliance for Regulated Environments

Post a comment about this story